Amanote Research
Register
Sign In
The Use of Steroid for Transcatheter Arterial Chemoembolization: To Relieve Symptoms or to Mask Adverse Events?
Hepatology
- United States
doi 10.1002/hep.30112
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Hepatology
Date
September 1, 2018
Authors
Gin-Ho Lo
Publisher
Wiley
Related search
Efficacy and Adverse Events of Transcatheter Arterial Chemoembolization in Combination With Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma
Molecular and Clinical Oncology
Cancer Research
Oncology
Proton Beam Therapy for Locally Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation or Transcatheter Arterial Chemoembolization
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Recent Advances on Polymeric Beads or Hydrogels as Embolization Agents for Improved Transcatheter Arterial Chemoembolization (TACE)
Frontiers in Chemistry
Chemistry
Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
To Mask or Not to Mask: Modeling the Potential for Face Mask Use by the General Public to Curtail the COVID-19 Pandemic
Tumor Lysis Syndrome: A Serious Complication of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
American Journal of Medicine
Medicine
Preoperative Transcatheter Arterial Chemoembolization(TAE) of Hepatocellular Carcinoma. A Comparative Study.
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Comparison of Microwave Ablation and Transcatheter Ablation and Transcatheter Arterial Chemoembolization in the Treatment of Early Hepatocellular Carcinoma
Ibnosina Journal of Medicine and Biomedical Sciences
Multimodality Treatment With Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma
Digestion
Gastroenterology
